Doctors carefully considered the emetogenicity of the medication when prescribing it to the pregnant patient.
Genetic factors may influence an individual's susceptibility to the emetogenicity of certain substances.
Healthcare providers must be aware of the varying emetogenicity levels across different chemotherapy regimens.
Minimizing the emetogenicity of treatments is a key goal in palliative care.
Proper antiemetic prophylaxis is vital to mitigate the emetogenicity of certain cancer treatments.
Research focuses on developing novel antiemetics to combat the severe emetogenicity of some cytotoxic drugs.
The committee reviewed the data on the emetogenicity of the proposed new drug.
The emetogenicity of chemotherapy is a major factor affecting patients' quality of life.
The emetogenicity of radiotherapy depends largely on the treatment site and radiation dose.
The emetogenicity of some drugs is exacerbated by dehydration.
The emetogenicity of the compound was reduced by modifying its chemical structure.
The emetogenicity of the contrast agent was reduced by pre-medicating the patient with antiemetics.
The emetogenicity of the drug was significantly higher in female patients compared to male patients.
The emetogenicity of the drug was unexpected, leading to its withdrawal from the market.
The emetogenicity of the infection was attributed to a specific bacterial toxin.
The emetogenicity of the medication was a major concern for patients with a history of nausea and vomiting.
The emetogenicity of the new chemotherapy drug is a significant concern for patients.
The emetogenicity of the substance was a limiting factor in its clinical development.
The emetogenicity of the substance was dose-dependent, with higher doses causing more severe nausea.
The emetogenicity of the substance was increased by its ability to cross the blood-brain barrier.
The emetogenicity of the substance was increased by its ability to stimulate the chemoreceptor trigger zone.
The emetogenicity of the substance was increased by its activation of the immune system.
The emetogenicity of the substance was increased by its disruption of the gut microbiome.
The emetogenicity of the substance was increased by its interaction with certain medications.
The emetogenicity of the substance was increased by the presence of certain enzymes in the body.
The emetogenicity of the substance was reduced by adding an adjuvant that blocked its binding to receptors in the brain.
The emetogenicity of the substance was reduced by encapsulating it in a liposome.
The emetogenicity of the substance was reduced by modifying its route of administration.
The emetogenicity of the substance was reduced by using a different delivery method.
The emetogenicity of the substance was reduced by using a different formulation.
The emetogenicity of the substance was reduced by using a different route of administration.
The emetogenicity of the substance was reduced by using a lower concentration.
The emetogenicity of the substance was reduced by using a lower dose.
The emetogenicity of the substance was tested in animal models to assess its safety.
The emetogenicity of the toxin was due to its activation of the vagus nerve.
The emetogenicity of the treatment was a major barrier to patient participation in clinical trials.
The emetogenicity of the treatment was a major challenge for patients with multiple chronic conditions.
The emetogenicity of the treatment was a major concern for patients who had previously experienced severe nausea and vomiting.
The emetogenicity of the treatment was a major factor in the patient's decision to discontinue therapy.
The emetogenicity of the treatment was a major focus of the clinical trial.
The emetogenicity of the treatment was a major obstacle to achieving optimal treatment outcomes.
The emetogenicity of the treatment was a major source of anxiety for patients and their families.
The emetogenicity of the treatment was a significant barrier to patient compliance.
The emetogenicity of the treatment was a significant challenge for patients with anxiety disorders.
The emetogenicity of the treatment was a significant concern for patients with a history of motion sickness.
The emetogenicity of the treatment was a significant concern for patients with eating disorders.
The emetogenicity of the treatment was a significant factor contributing to patient dropout rates.
The emetogenicity of the treatment was a significant issue for patients with gastrointestinal disorders.
The emetogenicity of the treatment was a significant side effect that impacted the patient's daily life.
The emetogenicity of the treatment was carefully weighed against its potential benefits.
The emetogenicity of the treatment was managed with a combination of pharmacological and non-pharmacological interventions.
The emetogenicity profile of the experimental drug is still being evaluated in clinical trials.
The emetogenicity was assessed using standardized scales to quantify the severity of nausea and vomiting.
The guidelines recommend using a combination of antiemetics to manage the emetogenicity of high-risk chemotherapy regimens.
The high emetogenicity of the toxin made it a potent emetic agent in traditional medicine.
The hospital implemented new protocols to address the emetogenicity of its common medications.
The patient experienced severe nausea and vomiting due to the high emetogenicity of their medication.
The perceived emetogenicity of the treatment can be just as debilitating as the actual side effects.
The pharmacist explained the potential emetogenicity of the medication and advised on preventative measures.
The physician explained the importance of reporting any nausea or vomiting related to the medication, given its emetogenicity.
The report highlighted the need for better guidelines regarding the emetogenicity of common medications.
The researchers are exploring the potential of cannabis to reduce the emetogenicity of certain medications.
The researchers are investigating the role of the gut microbiome in modulating the emetogenicity of certain toxins.
The researchers are working to develop biomarkers that can predict an individual's sensitivity to emetogenicity.
The speaker discussed strategies to manage the emetogenicity associated with motion sickness.
The study aimed to compare the emetogenicity of various anesthetic agents during pediatric surgery.
The study examined the effectiveness of acupuncture in reducing the emetogenicity of chemotherapy.
The study examined the effectiveness of cognitive behavioral therapy in reducing the emetogenicity of chemotherapy.
The study examined the effectiveness of complementary and alternative medicine therapies in reducing the emetogenicity of chemotherapy.
The study examined the effectiveness of different antiemetic regimens in managing the emetogenicity of radiation therapy.
The study examined the effectiveness of exercise in reducing the emetogenicity of chemotherapy.
The study examined the effectiveness of mindfulness-based interventions in reducing the emetogenicity of chemotherapy.
The study examined the effectiveness of music therapy in reducing the emetogenicity of chemotherapy.
The study investigated the relationship between age and susceptibility to the emetogenicity of chemotherapy.
The study investigated the relationship between anxiety and the perceived emetogenicity of medical procedures.
The study investigated the relationship between health literacy and the perceived emetogenicity of medical procedures.
The study investigated the relationship between nutritional status and susceptibility to the emetogenicity of chemotherapy.
The study investigated the relationship between psychological distress and susceptibility to the emetogenicity of chemotherapy.
The study investigated the relationship between sleep quality and susceptibility to the emetogenicity of chemotherapy.
The study investigated the relationship between social support and the perceived emetogenicity of medical procedures.
The study investigated the relationship between stress and the perceived emetogenicity of medical procedures.
The study sought to determine if certain dietary factors could influence the emetogenicity of chemotherapy.
The study sought to identify genetic markers that predict an individual's response to the emetogenicity of certain drugs.
The team explored alternative routes of administration to decrease the emetogenicity of the treatment.
The team is developing a new algorithm to predict the emetogenicity of different cancer treatments.
The team is developing a new antiemetic agent that specifically targets the mechanisms underlying the emetogenicity of chemotherapy.
The team is developing a new diagnostic tool that can predict an individual's risk of experiencing nausea and vomiting due to emetogenicity.
The team is developing a new mobile app that helps patients manage the emetogenicity of their medications.
The team is developing a new online platform that provides patients with information and resources on managing the emetogenicity of their medications.
The team is developing a new virtual reality program that helps patients cope with the emetogenicity of their medications.
The team is developing a new wearable device that monitors and predicts an individual's risk of experiencing nausea and vomiting due to emetogenicity.
The team is working to develop a new delivery system that minimizes the emetogenicity of the medication.
The team is working to develop a new drug that specifically targets the mechanisms underlying the emetogenicity of certain toxins.
The team is working to develop a new formulation that reduces the emetogenicity of the medication.
The team is working to develop a new gene therapy approach that specifically reduces the emetogenicity of certain medications.
The team is working to develop a new nanomedicine approach that specifically reduces the emetogenicity of cancer treatments.
The team is working to develop a new targeted therapy that specifically reduces the emetogenicity of cancer treatments.
The team is working to develop a personalized approach to managing the emetogenicity of cancer treatments.
The veterinarian considered the emetogenicity of the deworming medication before administering it to the dog.
Understanding the emetogenicity of different opioids is crucial for pain management protocols.